# Tolerability of maintenance olaparib in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation in the randomized phase III SOLO1 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/tolerability-of-maintenance-olaparib-in-newly-diagnosed-patients-with-advanced/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Nicoletta Colombo,Kathleen N. Moore,Giovanni Scambia,Ana Oaknin,Michael Friedländer,Alla Lisyanskaya,Anne Floquet,Alexandra Léary,Gabe S. Sonke,Charlie Gourley,Susana Banerjee,Amit M. Oza,Antonio González-Martı́n,Carol Aghajanian,William H. Bradley,Jae‐Weon Kim,Cara Mathews,Joyce F. Liu,Elizabeth Lowe,Ralph Bloomfield,Paul DiSilvestro |
| Citations | 37 |
| DOI | 10.1016/j.ygyno.2021.07.016 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1016/j.ygyno.2021.07.016 |
| OpenAlex ID | https://openalex.org/W3190145293 |
| PMID | 34353615 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Nicoletta Colombo](https://scholariq.org/researchers/nicoletta-colombo/)
- [Michael Friedländer](https://scholariq.org/researchers/michael-friedlander/)
- [Giovanni Scambia](https://scholariq.org/researchers/giovanni-scambia/)
- [Carol Aghajanian](https://scholariq.org/researchers/carol-aghajanian/)
- [Amit M. Oza](https://scholariq.org/researchers/amit-m-oza/)

## Paper funders

- [AstraZeneca](https://scholariq.org/funders/astrazeneca/)
- [National Cancer Institute](https://scholariq.org/funders/national-cancer-institute/)

## Paper journal

- [Gynecologic Oncology](https://scholariq.org/journals/gynecologic-oncology/)

## Paper primary topic

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

## Paper topics

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.